Denosumab Treatment in CKD Patients at High Risk of Fracture

Clinical trial NCT05692297 · UNKNOWN

Trial details

NCT number: NCT05692297
Sponsor: Capital Medical University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Kidney Diseases Fracture Bone Density, Low End Stage Renal Disease

Start date: 2023-01-01
Primary completion: 2025-12-31
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.